Sanofi, GSK, Pfizer and Boehringer must face Zantac class-action lawsuits, court rules

Sanofi, GSK, Pfizer and Boehringer must face Zantac class-action lawsuits, court rules

Source: 
Fierce Pharma
snippet: 

Even after the global Zantac recalls of 2019 and 2020 and the associated controversy, the courtroom saga over the medicine's risk is just getting started. This week, branded drugmakers GlaxoSmithKline, Sanofi, Pfizer and Boehringer Ingelheim lost an attempt to escape class-action lawsuits over their marketing of the decades-old drug.